For episode 25, we sit down with Dr. Paul Lammers, CEO of Triumvira Immunologics. Stay tuned to learn why having...
All Categories
ChatGPT for Drug Development? How Large Language Models Are Changing Drug Discovery
What is ChatGPT? ChatGPT (Chat Generative Pre-trained Transformer) is a large language model (LLM)-based artificial intelligence (AI) released by OpenAI...
Top 5 Challenges of Running Esophageal Cancer Clinical Trials
With over 550,000 new cases diagnosed each year, esophageal cancer is the seventh most common type of cancer worldwide. The...
San Francisco’s Top 6 CROs Specializing in Rare Disease Clinical Trials
Rare diseases are conditions with a low prevalence which can be severe, life-threatening, and disabling. Due to an inconsistency in...
First in Human Episode #24 featuring Gun-ho Kim
For episode 24, we speak with Gun-ho Kim, CEO & Founder of Recens Medical. Find out about the Ocu-Cool system:...
The Rise of Biotech Podcasts: The New Frontier of Knowledge Discovery
Podcasts have come a long way from their humble beginnings in the 2000s. There are millions of series hosted on...
The Role of GPT-4 in Drug Discovery
GPT-4 is a generative AI model that responds to text and images. You’re probably familiar with ChatGPT, which is a...
First in Human Episode #23 featuring Sam Whitaker
Sitting down with Sam Whitaker for episode 23, Co-Founder & Co-CEO of Mural Health. We learn about a common feature...
CROs and the Regulatory Landscape: How to Ensure Clinical Trial Compliance
Although it may be surprising to consider, today’s stringent governing oversight of clinical trial activities is, in fact, a relatively...
